The Effects of Diabetes Mellitus and Obesity to Pelvic Organ Prolapse in Postmenopausal Women

Yıl 2011, Cilt: 3 Sayı: 1, 21 - 27, 01.04.2011

Hakan Coksuer Berna Haliloğlu Mutlu Ercan Mesut Kose Uğur Keskin İbrahim Alanbay Emre Karaşahin Canan Kabaca Ateş Karateke

Öz

Objective: We aim to evaluate the effect of diabetes and obesity on pelvic organ prolapse POP in postmenopausal women. Methods: 104 women with POP, ages 49 to 79 were divided as group I non diabetic-non obese , group II non obese-diabetic , group III obese-non diabetic and group IV obese-diabetic . For each group, presence of uterine prolapse, cystocele and rectocele using POP Quantification POP-Q system were assessed. Results: Obesity and diabetes mellitus DM were associated with progression in cystocoele, rectocele and uterine prolapse compared with healthy women p

Anahtar Kelimeler

cystocele, diabetes mellitus, obesity, pelvic organ prolapse, rectocele and uterine prolapse

Diabetes Mellitus ve Obezitenin Postmenopozal Dönemdeki Kadınlardaki Pelvik Organ Prolapsusu Üzerine Etkileri

Öz

Amaç: Diabetes mellitus ve obezitenin postmenopozal dönemdeki kadınlarda pelvik organ prolapsusuna POP olan etkilerini değerlendirmeyi amaçladık. Yöntemler: 49-79 yaşları arasındaki POP bulunan 104 kadın grup I non-diabetik ve non-obez grup II non-obez ve diabetik grup III obez ve non-diabetik ve grup IV obez ve diabetik olmak üzere 4 gruba ayrılmıştır. Her bir grupta POP-Q POP-Q sistemi kullanılarak uterin prolapsus, sistosel ve rektosel varlığı değerlendirildi. Bulgular: Sağlıklı kadınlarla karşılaştırıldığında obezitenin ve diabetes mellitusun DM sistosel, rektosel ve uterin prolapsus progresyonuyla ilişkili olduğu saptanmıştır p

Anahtar Kelimeler

sistosel, diabetes mellitus, obezite, pelvic organ prolapsus, rektosel ve uterine prolapsus

Kaynakça

• 1) Gerten KA, Markland AD, Lloyd LK, Richter HE.: Prolapse and incontinence surgery in older women. J Urol 2008; 179:2111-2118.
• 2) MacLennan AH, Taylor AW, Wilson DH, Wilson D.: The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Br J Obstet Gynaecol 2000;107:1460–1470.
• 3) Bump RC, Norton PA.: Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998; 25:723–746.
• 4) Mant J, Painter R, Vessey M.: Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol 1997; 104:579-585.
• 5) Progetto Menopausa Italia Study Group. Risk factors for genital prolapse in non-hysterectomized women around menopause: results from a large crosssectional study in menopausal clinics in Italy. Eur J Obstet Gynecol Reprod Biol 2000; 93:135-140.
• 6) Nygaard I, Bradley C, Brandt D.: Women’s Health Initiative. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 2004;104:489-497.
• 7) Goldstein SR, Neven P, Zhou L, Taylor YL, Ciaccia AV, Plouffe L.: Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol 2001; 98: 91-96.
• 8) Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A.: Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186:1160+1166.
• 9) Mant J, Painter R, Vessey M.: Epidemiology of genital prolapse: observations from the Oxford family planning association study. BJOG 1997; 104: 579- 585. 10) Moalli PA, Jones Ivy S, Meyn LA, Zyczynski HM. Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol 2003; 101: 869-874.
• 11) Luber KM, Boero S, Choe JY.: The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 2001; 184:1496- 1501.
• 12) Sampselle CM, Wyman JF, Thomas KK, Newman DK, Gray M, Dougherty M, et al.: Continence for women: evaluation of AWHONN's third research utilization project. Association of Women's Health Obstetric and Neonatal Nurses. J Obstet Gynecol Neonatal Nurs 2000; 29:9-17.
• 13) American College of Obstetricians and Gynecologists. Pelvic organ prolapse. ACOG Technical Bulletin 214. Washington, DC: ACOG. 1995.
• 14) Bump RC, Mattiasson A, Bo K.: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10-17.
• 15) Blakeman A, Hilton A, Bulmer JN.: Mapping oestrogen and progesterone receptors throughout the female lower urinary tract. Abstracts from the 26th Annual Meeting of the International Continence Society. Neurologic Urodynamics 1996; 15:324-325.
• 16) Cicinelli E, Einer-Jensen N, Galantino P, Pinto V, Barba B, Tartangni M.: Model of counter-current transfer from vagina to urethra in postmenopausal women.Human Reproduction 2001; 16:2496-2500.
• 17) Robinson D, Cardozo L.: The role of estrogens in female lower urinary tract dysfunction. Urology 2003; 62:45-51.
• 18) Vardy M, Lindsay R, Scotti R, Mikhail M, Richart R, Nieves J, et al.: Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 2003; 189:81-88.
• 19) Kim SW, Kim NN, Jeong SJ, Munarriz R, Goldstein I, Traish AM.: Modulation of rat vaginal blood flow and estrogen receptor by estradiol. J Urol 2004; 172:1538-1543.
• 20) Pessina, MA; Hoyt, RF; Goldstein, I; Traish, AM.: Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinol.ogy 2006;147:161-169.
• 21) Christ GJ, Hodges S.: Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction. Br J Pharmacol 2006; 147 : 41-55.
• 22) Daneshgari F, Moore C.: Diabetic uropathy. Semin Nephrol 2006; 26:182-185.
• 23) Boreham MK, Wai CY, Miller RT, Schaffer JI, Word RA.: Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 2002; 187:56-63.
• 24) Lin SY, Tee YT, Ng SC, Chang H, Lin PP, Chen GD.: Changes in the extracellular matrix in the anterior vagina of women with or without prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2006; 18:43-48.
• 25) Wong MY, Harmanli OH, Agar M, Dandolu V, Grody MHT.: Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol 2003; 189:1597-1600.
• 26) Norton PA.: Pelvic floor disorders: The role of fascia and ligaments. Clin Obstet Gynecol 1993; 36:926- 938.
• 27) Lubowski DZ, Swash M, Nicholls RJ, Henry MM.: Increase in pudendal nerve terminal motor latency with defaecation straining. Br J Surg 1988; 75:1095- 1097.
• 28) Sapsford RR, Hodges PW.: Contraction of the pelvic floor muscles during abdominal maneuvers. Arch Phys Med Rehabil 2001; 82:1081-1088.
• 29) Moalli PA, Ivy SJ, Meyn LA, Zyczynski HM.: Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol 2003;101:869-874.
• 30) Lawrence JM, Charles WN, Emily SL, Karl ML, In-Lu AL.: Pelvic Floor Disorders, Diabetes, and Obesity in Women. Diabetes Care 2007; 30:2536-2541.